Histone Deacetylases Suppress CGG Repeat–Induced Neurodegeneration Via Transcriptional Silencing in Models of Fragile X Tremor Ataxia Syndrome

English version České info

Fragile X Tremor Ataxia Syndrome (FXTAS) is a common inherited neurodegenerative disorder caused by expansion of a CGG trinucleotide repeat in the 5′UTR of the fragile X syndrome (FXS) gene, FMR1. The expanded CGG repeat is thought to induce toxicity as RNA, and in FXTAS patients mRNA levels for FMR1 are markedly increased. Despite the critical role of FMR1 mRNA in disease pathogenesis, the basis for the increase in FMR1 mRNA expression is unknown. Here we show that overexpressing any of three histone deacetylases (HDACs 3, 6, or 11) suppresses CGG repeat–induced neurodegeneration in a Drosophila model of FXTAS. This suppression results from selective transcriptional repression of the CGG repeat–containing transgene. These findings led us to evaluate the acetylation state of histones at the human FMR1 locus. In patient-derived lymphoblasts and fibroblasts, we determined by chromatin immunoprecipitation that there is increased acetylation of histones at the FMR1 locus in pre-mutation carriers compared to control or FXS derived cell lines. These epigenetic changes correlate with elevated FMR1 mRNA expression in pre-mutation cell lines. Consistent with this finding, histone acetyltransferase (HAT) inhibitors repress FMR1 mRNA expression to control levels in pre-mutation carrier cell lines and extend lifespan in CGG repeat–expressing Drosophila. These findings support a disease model whereby the CGG repeat expansion in FXTAS promotes chromatin remodeling in cis, which in turn increases expression of the toxic FMR1 mRNA. Moreover, these results provide proof of principle that HAT inhibitors or HDAC activators might be used to selectively repress transcription at the FMR1 locus.

Vyšlo v časopise: Histone Deacetylases Suppress CGG Repeat–Induced Neurodegeneration Via Transcriptional Silencing in Models of Fragile X Tremor Ataxia Syndrome. PLoS Genet 6(12): e32767. doi:10.1371/journal.pgen.1001240
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.pgen.1001240

Souhrn

Zdroje

1. JacquemontS

HagermanRJ

LeeheyMA

HallDA

LevineRA

2004 Penetrance of the fragile X-associated tremor/ataxia syndrome in a premutation carrier population. JAMA 291 460 469

2. HagermanPJ

HagermanRJ

2004 The fragile-X premutation: a maturing perspective. Am J Hum Genet 74 805 816

3. GrecoCM

BermanRF

MartinRM

TassoneF

SchwartzPH

2006 Neuropathology of fragile X-associated tremor/ataxia syndrome (FXTAS). Brain 129 243 255

4. GrecoCM

HagermanRJ

TassoneF

ChudleyAE

Del BigioMR

2002 Neuronal intranuclear inclusions in a new cerebellar tremor/ataxia syndrome among fragile X carriers. Brain 125 1760 1771

5. TassoneF

HagermanRJ

TaylorAK

GaneLW

GodfreyTE

2000 Elevated levels of FMR1 mRNA in carrier males: a new mechanism of involvement in the fragile-X syndrome. Am J Hum Genet 66 6 15

6. TassoneF

HagermanRJ

TaylorAK

MillsJB

HarrisSW

2000 Clinical involvement and protein expression in individuals with the FMR1 premutation. Am J Med Genet 91 144 152

7. PrimeranoB

TassoneF

HagermanRJ

HagermanP

AmaldiF

2002 Reduced FMR1 mRNA translation efficiency in fragile X patients with premutations. RNA 8 1482 1488

8. ChenLS

TassoneF

SahotaP

HagermanPJ

2003 The (CGG)n repeat element within the 5′ untranslated region of the FMR1 message provides both positive and negative cis effects on in vivo translation of a downstream reporter. Hum Mol Genet 12 3067 3074

9. BrouwerJR

HuizerK

SeverijnenLA

HukemaRK

BermanRF

2008 CGG-repeat length and neuropathological and molecular correlates in a mouse model for fragile X-associated tremor/ataxia syndrome. J Neurochem 107 1671 1682

10. BrouwerJR

MientjesEJ

BakkerCE

NieuwenhuizenIM

SeverijnenLA

2007 Elevated Fmr1 mRNA levels and reduced protein expression in a mouse model with an unmethylated Fragile X full mutation. Exp Cell Res 313 244 253

11. WillemsenR

Hoogeveen-WesterveldM

ReisS

HolstegeJ

SeverijnenLA

2003 The FMR1 CGG repeat mouse displays ubiquitin-positive intranuclear neuronal inclusions; implications for the cerebellar tremor/ataxia syndrome. Hum Mol Genet 12 949 959

12. PeprahE

HeW

AllenE

OliverT

BoyneA

2010 Examination of FMR1 transcript and protein levels among 74 premutation carriers. J Hum Genet 55 66 68

13. JinP

ZarnescuDC

ZhangF

PearsonCE

LucchesiJC

2003 RNA-mediated neurodegeneration caused by the fragile X premutation rCGG repeats in Drosophila. Neuron 39 739 747

14. ArocenaDG

IwahashiCK

WonN

BeilinaA

LudwigAL

2005 Induction of inclusion formation and disruption of lamin A/C structure by premutation CGG-repeat RNA in human cultured neural cells. Hum Mol Genet 14 3661 3671

15. HandaV

GoldwaterD

StilesD

CamM

PoyG

2005 Long CGG-repeat tracts are toxic to human cells: implications for carriers of Fragile X premutation alleles. FEBS Lett 579 2702 2708

16. HashemV

GallowayJN

MoriM

WillemsenR

OostraBA

2009 Ectopic expression of CGG containing mRNA is neurotoxic in mammals. Hum Mol Genet

17. IwahashiCK

YasuiDH

AnHJ

GrecoCM

TassoneF

2006 Protein composition of the intranuclear inclusions of FXTAS. Brain 129 256 271

18. JinP

DuanR

QurashiA

QinY

TianD

2007 Pur alpha binds to rCGG repeats and modulates repeat-mediated neurodegeneration in a Drosophila model of fragile X tremor/ataxia syndrome. Neuron 55 556 564

19. SofolaOA

JinP

QinY

DuanR

LiuH

2007 RNA-binding proteins hnRNP A2/B1 and CUGBP1 suppress fragile X CGG premutation repeat-induced neurodegeneration in a Drosophila model of FXTAS. Neuron 55 565 571

20. SellierC

RauF

LiuY

TassoneF

HukemaRK

2010 Sam68 sequestration and partial loss of function are associated with splicing alterations in FXTAS patients. EMBO J

21. ZangJB

NosyrevaED

SpencerCM

VolkLJ

MusunuruK

2009 A mouse model of the human Fragile X syndrome I304N mutation. PLoS Genet 5 e1000758 doi:10.1371/journal.pgen.1000758

22. PietrobonoR

TabolacciE

ZalfaF

ZitoI

TerraccianoA

2005 Molecular dissection of the events leading to inactivation of the FMR1 gene. Hum Mol Genet 14 267 277

23. TabolacciE

MoscatoU

ZalfaF

BagniC

ChiurazziP

2008 Epigenetic analysis reveals a euchromatic configuration in the FMR1 unmethylated full mutations. Eur J Hum Genet 16 1487 1498

24. FengY

ZhangF

LokeyLK

ChastainJL

LakkisL

1995 Translational suppression by trinucleotide repeat expansion at FMR1. Science 268 731 734

25. TassoneF

BeilinaA

CarosiC

AlbertosiS

BagniC

2007 Elevated FMR1 mRNA in premutation carriers is due to increased transcription. RNA 13 555 562

26. MulvihillDJ

Nichol EdamuraK

HagermanKA

PearsonCE

WangYH

2005 Effect of CAT or AGG interruptions and CpG methylation on nucleosome assembly upon trinucleotide repeats on spinocerebellar ataxia, type 1 and fragile X syndrome. J Biol Chem 280 4498 4503

27. WangYH

GellibolianR

ShimizuM

WellsRD

GriffithJ

1996 Long CCG triplet repeat blocks exclude nucleosomes: a possible mechanism for the nature of fragile sites in chromosomes. J Mol Biol 263 511 516

28. ChoY

GriswoldA

CampbellC

MinKT

2005 Individual histone deacetylases in Drosophila modulate transcription of distinct genes. Genomics 86 606 617

29. NedelskyNB

ToddPK

TaylorJP

2008 Autophagy and the ubiquitin-proteasome system: collaborators in neuroprotection. Biochim Biophys Acta 1782 691 699

30. PandeyUB

NieZ

BatleviY

McCrayBA

RitsonGP

2007 HDAC6 rescues neurodegeneration and provides an essential link between autophagy and the UPS. Nature 447 859 863

31. SteffanJS

BodaiL

PallosJ

PoelmanM

McCampbellA

2001 Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila. Nature 413 739 743

32. BarlowAL

van DrunenCM

JohnsonCA

TweedieS

BirdA

2001 dSIR2 and dHDAC6: two novel, inhibitor-resistant deacetylases in Drosophila melanogaster. Exp Cell Res 265 90 103

33. DuG

LiuX

ChenX

SongM

YanY

Drosophila histone deacetylase 6 protects dopaminergic neurons against {alpha}-synuclein toxicity by promoting inclusion formation. Mol Biol Cell 21 2128 2137

34. PallosJ

BodaiL

LukacsovichT

PurcellJM

SteffanJS

2008 Inhibition of specific HDACs and sirtuins suppresses pathogenesis in a Drosophila model of Huntington's disease. Hum Mol Genet 17 3767 3775

35. StrahlBD

AllisCD

2000 The language of covalent histone modifications. Nature 403 41 45

36. CoffeeB

ZhangF

CemanS

WarrenST

ReinesD

2002 Histone modifications depict an aberrantly heterochromatinized FMR1 gene in fragile x syndrome. Am J Hum Genet 71 923 932

37. CoffeeB

ZhangF

WarrenST

ReinesD

1999 Acetylated histones are associated with FMR1 in normal but not fragile X-syndrome cells. Nat Genet 22 98 101

38. BiacsiR

KumariD

UsdinK

2008 SIRT1 inhibition alleviates gene silencing in Fragile X mental retardation syndrome. PLoS Genet 4 e1000017 doi:10.1371/journal.pgen.1000017

39. HabibM

FaresF

BourgeoisCA

BellaC

BernardinoJ

1999 DNA global hypomethylation in EBV-transformed interphase nuclei. Exp Cell Res 249 46 53

40. BrennanEP

EhrichM

BrazilDP

CreanJK

MurphyM

2009 Comparative analysis of DNA methylation profiles in peripheral blood leukocytes versus lymphoblastoid cell lines. Epigenetics 4 159 164

41. GrafodatskayaD

ChoufaniS

FerreiraJC

ButcherDT

LouY

EBV transformation and cell culturing destabilizes DNA methylation in human lymphoblastoid cell lines. Genomics 95 73 83

42. Garcia-ArocenaD

YangJE

BrouwerJR

TassoneF

IwahashiC

Fibroblast phenotype in male carriers of FMR1 premutation alleles. Hum Mol Genet 19 299 312

43. ShahbazianMD

GrunsteinM

2007 Functions of site-specific histone acetylation and deacetylation. Annu Rev Biochem 76 75 100

44. BalasubramanyamK

AltafM

VarierRA

SwaminathanV

RavindranA

2004 Polyisoprenylated benzophenone, garcinol, a natural histone acetyltransferase inhibitor, represses chromatin transcription and alters global gene expression. J Biol Chem 279 33716 33726

45. BalasubramanyamK

SwaminathanV

RanganathanA

KunduTK

2003 Small molecule modulators of histone acetyltransferase p300. J Biol Chem 278 19134 19140

46. PanMH

ChangWL

Lin-ShiauSY

HoCT

LinJK

2001 Induction of apoptosis by garcinol and curcumin through cytochrome c release and activation of caspases in human leukemia HL-60 cells. J Agric Food Chem 49 1464 1474

47. OsterwalderT

YoonKS

WhiteBH

KeshishianH

2001 A conditional tissue-specific transgene expression system using inducible GAL4. Proc Natl Acad Sci U S A 98 12596 12601

48. EntezamA

BiacsiR

OrrisonB

SahaT

HoffmanGE

2007 Regional FMRP deficits and large repeat expansions into the full mutation range in a new Fragile X premutation mouse model. Gene 395 125 134

49. UsdinK

2008 The biological effects of simple tandem repeats: lessons from the repeat expansion diseases. Genome Res 18 1011 1019

50. ThomsonJP

SkenePJ

SelfridgeJ

ClouaireT

GuyJ

CpG islands influence chromatin structure via the CpG-binding protein Cfp1. Nature 464 1082 1086

51. SutcliffeJS

NelsonDL

ZhangF

PierettiM

CaskeyCT

1992 DNA methylation represses FMR-1 transcription in fragile X syndrome. Hum Mol Genet 1 397 400

52. HornstraIK

NelsonDL

WarrenST

YangTP

1993 High resolution methylation analysis of the FMR1 gene trinucleotide repeat region in fragile X syndrome. Hum Mol Genet 2 1659 1665

53. TabolacciE

De PascalisI

AccadiaM

TerraccianoA

MoscatoU

2008 Modest reactivation of the mutant FMR1 gene by valproic acid is accompanied by histone modifications but not DNA demethylation. Pharmacogenet Genomics 18 738 741

54. TorrioliM

VernacotolaS

SetiniC

BevilacquaF

MartinelliD

Treatment with valproic acid ameliorates ADHD symptoms in fragile X syndrome boys. Am J Med Genet A 1420 1427

55. TabolacciE

PietrobonoR

MoscatoU

OostraBA

ChiurazziP

2005 Differential epigenetic modifications in the FMR1 gene of the fragile X syndrome after reactivating pharmacological treatments. Eur J Hum Genet 13 641 648

56. TassoneF

HagermanRJ

ChamberlainWD

HagermanPJ

2000 Transcription of the FMR1 gene in individuals with fragile X syndrome. Am J Med Genet 97 195 203

57. GrecoCM

SoontrapornchaiK

WirojananJ

GouldJE

HagermanPJ

2007 Testicular and pituitary inclusion formation in fragile X associated tremor/ataxia syndrome. J Urol 177 1434 1437

58. Rodriguez-RevengaL

MadrigalI

PagonabarragaJ

XunclaM

BadenasC

2009 Penetrance of FMR1 premutation associated pathologies in fragile X syndrome families. Eur J Hum Genet

59. LaddPD

SmithLE

RabaiaNA

MooreJM

GeorgesSA

2007 An antisense transcript spanning the CGG repeat region of FMR1 is upregulated in premutation carriers but silenced in full mutation individuals. Hum Mol Genet 16 3174 3187

60. SofolaOA

JinP

BotasJ

NelsonDL

2007 Argonaute-2-dependent rescue of a Drosophila model of FXTAS by FRAXE premutation repeat. Hum Mol Genet 16 2326 2332

61. LiaoCH

SangS

HoCT

LinJK

2005 Garcinol modulates tyrosine phosphorylation of FAK and subsequently induces apoptosis through down-regulation of Src, ERK, and Akt survival signaling in human colon cancer cells. J Cell Biochem 96 155 169

62. ItoC

ItoigawaM

MiyamotoY

OnodaS

RaoKS

2003 Polyprenylated benzophenones from Garcinia assigu and their potential cancer chemopreventive activities. J Nat Prod 66 206 209

63. AcevedoHR

RojasMD

ArceoSD

Soto HernandezM

Martinez VazquezM

2006 Effect of 6-nonadecyl salicylic acid and its methyl ester on the induction of micronuclei in polychromatic erythrocytes in mouse peripheral blood. Mutat Res 609 43 46

64. TanakaT

KohnoH

ShimadaR

KagamiS

YamaguchiF

2000 Prevention of colonic aberrant crypt foci by dietary feeding of garcinol in male F344 rats. Carcinogenesis 21 1183 1189

65. ChongSS

EichlerEE

NelsonDL

HughesMR

1994 Robust amplification and ethidium-visible detection of the fragile X syndrome CGG repeat using Pfu polymerase. Am J Med Genet 51 522 526

66. KramerPR

PearsonCE

SindenRR

1996 Stability of triplet repeats of myotonic dystrophy and fragile X loci in human mutator mismatch repair cell lines. Hum Genet 98 151 157

67. TassoneF

PanR

AmiriK

TaylorAK

HagermanPJ

2008 A rapid polymerase chain reaction-based screening method for identification of all expanded alleles of the fragile X (FMR1) gene in newborn and high-risk populations. J Mol Diagn 10 43 49

68. Kazemi-EsfarjaniP

BenzerS

2000 Genetic suppression of polyglutamine toxicity in Drosophila. Science 287 1837 1840

69. Rodriguez-LebronE

GouvionCM

MooreSA

DavidsonBL

PaulsonHL

2009 Allele-specific RNAi mitigates phenotypic progression in a transgenic model of Alzheimer's disease. Mol Ther 17 1563 1573

70. Berry-KravisE

AbramsL

CoffeySM